Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin versus azithromycin for induction of macrolide resistance in healthy volunteers
ACTRN12617000278336Phase 3Not yet recruiting
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial comparing Azithromycin with Erythromycin (2 arms). Primary endpoint: Difference between erythromycin and azithromycin in induction of macrolide resistance in commensal oropharyngeal flora of index participants. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
erythromycinazithromycin
Beyond the preview
Go deeper on ACTRN12617000278336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000278336.